The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression
Open accessAbstract
Despite advances in clinical therapy, metastasis remains the leading cause of death in breast cancer patients. Mutations in mitochondrial DNA, including those affecting complex I and oxidative phosphorylation, are found in breast tumors and could facilitate metastasis. This study identifies mitochondrial complex I as critical for defining an aggressive phenotype in breast cancer cells. Specific enhancement of mitochondrial complex I activity inhibited tumor growth and metastasis through regulation of the tumor cell NAD+/NADH redox balance, mTORC1 activity, and autophagy. Conversely, nonlethal reduction of NAD+ levels by interfering with nicotinamide phosphoribosyltransferase expression rendered tumor cells more aggressive and increased metastasis. The results translate into a new therapeutic strategy: enhancement of the NAD+/NADH balance through treatment with NAD+ precursors inhibited metastasis in xenograft models, increased animal survival, and strongly interfered with oncogene-driven breast cancer progression in the MMTV-PyMT mouse model. Thus, aberration in mitochondrial complex I NADH dehydrogenase activity can profoundly enhance the aggressiveness of human breast cancer cells, while therapeutic normalization of the NAD+/NADH balance can inhibit metastasis and prevent disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941 · cited 1×
“One of the main regulators of autophagy is mTORC1, which links tumor growth and metabolism (46).”
Autophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230
Autophagy Suppresses Tumorigenesis through Elimination of p62
Mathew, R., Karp, C. M., Beaudoin, B., Vuong, N., Chen, G., Chen, H.-Y., Bray, K., Reddy, A., Bhanot, G., Gelinas, C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.03.048 · Cited by 1,719
Cancer as an evolutionary and ecological process
Merlo, L. M. F., Pepper, J. W., Reid, B. J., & Maley, C. C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2013 · Cited by 1,699
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy
Lee, I. H., Cao, L., Mostoslavsky, R., Lombard, D. B., Liu, J., Bruns, N. E., Tsokos, M., Alt, F. W., & Finkel, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712145105 · Cited by 1,476
ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis
Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., & Hayashi, J.-I. (2008) · Science · doi:10.1126/science.1156906 · Cited by 1,444
Reactive oxygen species in cancer cells: Live by the sword, die by the sword
Schumacker, P. T. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.015 · Cited by 1,242
Heterogeneity in breast cancer
Polyak, K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci60534 · Cited by 1,006
SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1
Lan, F., Cacicedo, J. M., Ruderman, N., & Ido, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805711200 · Cited by 825
Mitochondrial mutations in cancer
Brandon, M., Baldi, P., & Wallace, D. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209607 · Cited by 818
Dawood, S., Broglio, K., Buzdar, A. U., Hortobagyi, G. N., & Giordano, S. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9844 · Cited by 758
Trounce, I. A., Kim, Y. L., Jun, A. S., & Wallace, D. C. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)64044-0 · Cited by 746
Mitochondrial defects in cancer.
Carew, J. S., & Huang, P. (2002) · Molecular Cancer · doi:10.1186/1476-4598-1-9 · Cited by 675
Kume, S., Uzu, T., Horiike, K., Chin-Kanasaki, M., Isshiki, K., Araki, S.-I., Sugimoto, T., Haneda, M., Kashiwagi, A., & Koya, D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41376 · Cited by 640
Hasmann, M., & Schemainda, I. (2003) · PubMed · Cited by 617
Pillai, V. B., Sundaresan, N. R., Kim, G., Gupta, M., Rajamohan, S. B., Pillai, J. B., Samant, S., Ravindra, P. V., Isbatan, A., & Gupta, M. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077271 · Cited by 419
SIRT1 Negatively Regulates the Mammalian Target of Rapamycin
Ghosh, H. S., McBurney, M., & Robbins, P. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009199 · Cited by 397
Pelicano, H., Xu, R.-H., Du, M., Feng, L., Sasaki, R., Carew, J. S., Hu, Y., Ramdas, L., Hu, L., Keating, M. J., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200512100 · Cited by 387
Adaptation of Energy Metabolism in Breast Cancer Brain Metastases
Chen, E. I., Hewel, J., Krueger, J. S., Tiraby, C., Weber, M. R., Kralli, A., Becker, K., Yates, J. R., & Felding-Habermann, B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3137 · Cited by 352
Self-citationSirtuins mediate mammalian metabolic responses to nutrient availability
Chalkiadaki, A., & Guarente, L. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.225 · Cited by 346
Autophagy and metastasis: another double-edged sword
Kenific, C. M., Thorburn, A., & Debnath, J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.10.008 · Cited by 311
Aging and disease: connections to sirtuins
Donmez, G., & Guarente, L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00548.x · Cited by 311
Hu, Y., Lu, W., Chen, G., Wang, P., Chen, Z., Zhou, Y., Ogasawara, M., Trachootham, D., Feng, L., Pelicano, H., et al. (2012) · Cell Research · doi:10.1038/cr.2011.145 · Cited by 304
Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates.
Parrella, P., Xiao, Y., Fliss, M., Sánchez‐Céspedes, M., Mazzarelli, P., Rinaldi, M., Nicol, T. L., Gabrielson, E. W., Cuomo, C., Cohen, D., et al. (2001) · PubMed · Cited by 279
Nicotinamide-induced Mitophagy
Jang, S.-Y., Kang, H. T., & Hwang, E. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.363747 · Cited by 262
Wang, B., Hasan, M. K., Alvarado, E., Yuan, H., Wu, H., & Chen, W. Y. (2011) · Oncogene · doi:10.1038/onc.2010.468 · Cited by 245
Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night
Mathew, R., & White, E. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.008 · Cited by 236
MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
Chambers, A. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1528 · Cited by 218
Redox sensor CtBP mediates hypoxia-induced tumor cell migration
Zhang, Q., Wang, S.-Y., Nottke, A. C., Rocheleau, J. V., Piston, D. W., & Goodman, R. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603269103 · Cited by 200
Seo, B. B., Kitajima-Ihara, T., Chan, E. K. L., Scheffler, I. E., Matsuno-Yagi, A., & Yagi, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9167 · Cited by 187
Self-citationSharma, L. K., Fang, H., Liu, J., Vartak, R. S., Deng, J., & Bai, Y. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr395 · Cited by 174
Loss of Complex I due to Mitochondrial DNA Mutations in Renal Oncocytoma
Mayr, J. A., Meierhofer, D., Zimmermann, F., Feichtinger, R., Kögler, C., Ratschek, M., Schmeller, N., Sperl, W., & Kofler, B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4131 · Cited by 174
Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin
LeBeau, A. M., Brennen, W. N., Aggarwal, S., & Denmeade, S. R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1170 · Cited by 159
(1980) · PubMed · Cited by 154
Sanz, A., Soikkeli, M., Portero‐Otín, M., Wilson, A. M., Kemppainen, E., Mcilroy, G. D., Ellilä, S., Kemppainen, K. K., Tuomela, T., Lakanmaa, M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911539107 · Cited by 149
Self-citationBaracca, A., Chiaradonna, F., Sgarbi, G., Solaini, G., Alberghina, L., & Lenaz, G. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.11.006 · Cited by 146
Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
Bajrami, I., Kigozi, A., Van Weverwijk, A., Brough, R., Frankum, J., Lord, C. J., & Ashworth, A. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201250 · Cited by 136
Compartmentation of NAD+‐dependent signalling
Koch‐Nolte, F., Fischer, S., Haag, F., & Ziegler, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.045 · Cited by 129
Schwartz, J. P., Passonneau, J. V., Johnson, G. S., & Pastan, I. H. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42494-0 · Cited by 113
Transcriptional regulation of BRCA1 expression by a metabolic switch
Di, L., Fernandez, A. G., Siervi, A. D., Longo, D. L., & Gardner, K. L. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1941 · Cited by 113
Cancer cell mitochondria confer apoptosis resistance and promote metastasis
Kulawiec, M., Owens, K. M., & Singh, K. K. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.14.8751 · Cited by 109
de Vries, S., WITZENBURG, R. V., Grivell, L. A., & Marres, C. A. M. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb16587.x · Cited by 105
Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids
Ma, Y., Bai, R., Trieu, R. B., & Wong, L. C. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.07.008 · Cited by 102
Dasgupta, S., Soudry, E., Mukhopadhyay, N. D., Shao, C., Yee, J., Lam, S., Lam, W. L., Zhang, W. Y., Gazdar, A. F., Fisher, P. B., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22980 · Cited by 92
Marella, M., Seo, B. B., Thomas, B. B., Matsuno‐Yagi, A., & Yagi, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011472 · Cited by 92
Self-citationSeo, B. B., Wang, J., Flotte, T. R., Yagi, T., & Matsuno‐Yagi, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007033200 · Cited by 85
Self-citationNiacin requirements for genomic stability
Kirkland, J. B. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.11.008 · Cited by 84
Mitochondrial complex I deficiency of nuclear origin
Pagniez-Mammeri, H., Loublier, S., Legrand, A., Bénit, P., Rustin, P., & Slama, A. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.11.188 · Cited by 69
Yokota, M., Shitara, H., Hashizume, O., Ishikawa, K., Nakada, K., Ishii, R., Taya, C., Takenaga, K., Yonekawa, H., & Hayashi, J. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.07.048 · Cited by 50
Fendt, L., Niederstätter, H., Huber, G. E., Zelger, B. G., Dünser, M., Seifarth, C., Röck, A. W., Schäfer, G., Klocker, H., & Parson, W. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1092-8 · Cited by 49
Tu, Y., Kaipparettu, B. A., Ma, Y., & Wong, L.-J. C. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.04.015 · Cited by 49
Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1
Deng, Y., Liu, J., Han, G., Lu, S.-L., Wang, S.-Y., Malkoski, S. P., Tan, A. C., Deng, C., Wang, X.-J., & Zhang, Q. (2010) · Oncogene · doi:10.1038/onc.2010.406 · Cited by 49
Respiratory chain complex I is a mitochondrial tumor suppressor of oncocytic tumors
Kofler, B. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e247 · Cited by 49
Mitochondrial complex I deficiency of nuclear origin
Pagniez-Mammeri, H., Rak, M., Legrand, A., Bénit, P., Rustin, P., & Slama, A. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.10.001 · Cited by 46
Barber‐Singh, J., Seo, B. B., Nakamaru‐Ogiso, E., Lau, Y., Matsuno‐Yagi, A., & Yagi, T. (2009) · Rejuvenation Research · doi:10.1089/rej.2009.0854 · Cited by 45
Self-citationVitamin B3, the nicotinamide adenine dinucleotides and aging
Xu, P., & Sauve, A. A. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.03.006 · Cited by 41
Evaluating mitochondrial DNA in patients with breast cancer and benign breast disease
Shen, L., Wei, J., Chen, T., He, J., Qu, J., He, X., Jiang, L., Qu, Y.-M., Fang, H., Chen, G., et al. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0912-x · Cited by 39
Perry, C. N., Huang, C., Liu, W., Magee, N., Carreira, R., & Gottlieb, R. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016288 · Cited by 29
No Immune Responses by the Expression of the Yeast Ndi1 Protein in Rats
Marella, M., Seo, B. B., Flotte, T. R., Matsuno‐Yagi, A., & Yagi, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025910 · Cited by 22
Self-citation
Research works printed but not linked: 3
- Parrella, 2001, Cancer Res., 61, 7623
- Hasmann, 2003, Cancer Res., 63, 7436
- Brinkley, 1980, Cancer Res., 40, 3118
Cited by
Birsoy, K., Wang, T., Chen, W. W., Freinkman, E., Abu-Remaileh, M., & Sabatini, D. M. (2015) · Cell · doi:10.1016/j.cell.2015.07.016 · Cited by 1,388
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
de la Cruz-López, K. G., Castro-Muñoz, L. J., Reyes-Hernández, D. O., García-Carrancá, A., & Manzo-Merino, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01143 · Cited by 940
“Currently it is known that, certain cancer cells may also actively use OXPHOS or a combination of OXPHOS and glycolysis for ATP production (45, 46).”
BackgroundTumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism
Zhao, H., Yang, L., Baddour, J., Achreja, A., Bernard, V., Moss, T., Marini, J. C., Tudawe, T., Seviour, E. G., San Lucas, F. A., et al. (2016) · eLife · doi:10.7554/elife.10250 · Cited by 927
“Although recent studies (Ishikawa et al., 2008; Santidrian et al., 2013), including our own (Yang et al.”
ResultGlutaminolysis: A Hallmark of Cancer Metabolism
Yang, L., Venneti, S., & Nagrath, D. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044546 · Cited by 859
Metadata
- Authors
- Santidrian, A. F., Matsuno-Yagi, A., Ritland, M., Seo, B. B., LeBoeuf, S. E., Gay, L. J., Yagi, T., & Felding-Habermann, B.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-02-15
- Volume
- 123
- Issue
- 3
- Pages
- 1068-1081
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2124276356
- Cited by
- 433
- References
- 65
- FWCI
- 11.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.